Corteva adds Arevo soy seed treatment to European portfolio
The arginine-based Arginex Soy treatment is being integrated after tests of performance, stability and fit with Corteva seed systems.
By Lucas Ferreira · Science & Environment Writer
2 min read
Corteva is adding Arevo’s Arginex Soy to its European soybean seed treatment portfolio, giving growers access to an arginine-based crop nutrition system through established seed channels. The move puts a biological-style nutrition tool into a major commercial seed treatment program at a time when farmers face pressure to improve nutrient efficiency and reduce fertiliser waste.
Arginex Soy is applied to seed and is aimed at supporting early soybean development. The companies said the product is intended to strengthen root growth, increase nodulation and improve nutrient-use efficiency, with potential benefits for crop performance and resilience.
The agreement follows a multi-stage technical evaluation by Corteva that looked at agronomic performance, formulation stability and compatibility with its current soybean seed treatment operations. Corteva said the review showed Arginex Soy could be used within existing seed treatment processes, which may make adoption easier for growers and seed partners.
Soybeans depend on nodules that host nitrogen-fixing bacteria, which convert atmospheric nitrogen into forms the plant can use. Root hairs play a central role in that process because they help create the sites where nodules form.
Arginine is an organic nitrogen source used in Arevo’s technology. In Arginex Soy, it is combined with phosphate to create a compound designed to remain available in the root zone over time, according to the companies.
The product is already available to farmers in Europe. By adding it to Corteva’s portfolio, the companies are targeting the earliest stages of crop establishment, when root development, nutrient uptake and microbial interaction can influence yield potential later in the season.
Leonardo Costa, Corteva Agriscience’s EMEA seed applied technologies leader, said the technical review found that Arginex Soy met Corteva’s requirements for consistency and formulation stability. He said the product gives farmers a practical way to support early establishment and nutrient-use efficiency from the start of the crop cycle.
Niklas Åström, Arevo’s chief executive, said selection after that level of technical review marked a milestone for the Swedish company and showed that Arginex can fit into established seed platforms.
The partnership places Arginex Soy seed treatment in Europe within the broader market for seed-applied technologies, a category that includes crop protection, biologicals and nutritional products placed directly on seed before planting. For growers, the appeal is that the treatment is delivered with the seed rather than as a separate field operation.
Arevo describes itself as a Swedish crop nutrition company focused on arginine-based technology for agriculture, forestry and horticulture. Corteva sells seed, crop protection and digital agriculture products globally and is listed on the New York Stock Exchange under the ticker CTVA.